Robert Poggie

Regulatory and R&D

Dr. Poggie (Bob) has worked in the orthopaedic industry since 1992, with experience and responsibilities in applied in research, clinical affairs, regulatory affairs, and medical education. Since 2008, Bob has been an independent consultant (BioVera Inc., Notre-Dame-de-L’Ile-Perrot, Quebec, Canada) to the industry, including consulting services provided to Biorez and its predecessor company STR Inc. on regulatory affairs, clinical strategy, and applied research.  Prior to BioVera, Bob was Director of Global Brand Management for Zimmer Trabecular Metal Technology, Inc. He wrote the FDA and international submissions that resulted in numerous regulatory clearances for spinal, hip, knee, and shoulder products, and created the training materials for prospective surgeon users and the company’s sales associates.

Prior to Zimmer, Bob was Director of Applied Research for Implex Corp. the original developer of Trabecular Metal. Bob managed the research, the lab and university testing, and the worldwide regulatory clearances of all the orthopedic products. Bob managed a small clinical department for FDA regulated investigational studies, which included the recruitment of surgeon investigators, clinical site data compilation, and publication results. Prior to Implex, Bob was a senior research engineer for Smith & Nephew, responsible for metallurgical and tribological research, which included Oxynium technology. Bob has published numerous peer reviewed papers and presented globally as invited faculty at over 100 medical conferences. He is a member of several professional engineering and medical societies, and holds a BE in Mechanical Engineering and MS and PhD degrees in Materials Science & Engineering, all from Vanderbilt University in Nashville, TN.

Our Core Team

Scientific Advisors

Board Advisors